SIRT3 and breast cancer: Finally, the interrogation of human breast cancer samples as measured via: (1) staining for protein levels; (2) RT-PCR for RNA levels; and (3) genomic analysis all showed a statistically significant decrease in SIRT3 levels in tumor cells, as compared to normal tissue controls.